The company has no funds in the bank; three of its four products have long been suspended due to lack of funds; and if that's not enough, the company has 190 million shares on issue - which will inevitably balloon to 250-300m if they are to raise necessary further capital.
Yet you speak of Virax as offering "leverage".
Leverage to the poor house if you ask me.
Add to My Watchlist
What is My Watchlist?
